Form 4 Tracker
Natera, Inc.
NTRA

118 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 23, 2026Jan 28 1:35 AMJonathan SheenaDirector, Other
Sale
1,500$243.94$365.9K21,782(I)

View →

Jan 21, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
1,590$235.00$373.6K219,150(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
71,932$234.74$16.9M217,354(D)

View →

Jan 21, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
37,175$242.54$9.0M64,123(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
23,948$234.74$5.6M99,776(D)

View →

Jan 21, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Sale
3,163$234.46$741.6K264,078(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Sale
2,981$234.74$699.8K267,050(D)

View →

Jan 21, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
438$235.00$102.9K227,033(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
19,234$234.74$4.5M226,615(D)

View →

Jan 21, 2026Jan 23 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
293$235.00$68.9K144,699(D)

View →

Jan 20, 2026Jan 23 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
23,205$234.74$5.4M144,992(D)

View →

Jan 21, 2026Jan 23 2:05 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
339$235.00$79.7K177,252(D)

View →

Jan 20, 2026Jan 23 2:05 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
17,806$234.74$4.2M177,591(D)

View →

Jan 21, 2026Jan 21 9:54 PMMICHAEL BROPHY
Proposed Sale
36,573$234.85$8.6M

View →

Jan 2, 2026Jan 2 9:13 PMSOLOMON MOSHKEVICH
Proposed Sale
2,951$228.95$675.6K

View →

Jan 2, 2026Jan 2 9:13 PMSTEVEN L CHAPMAN
Proposed Sale
3,848$229.08$881.5K

View →

Dec 19, 2025Dec 19 3:03 PMSheena Jonathan
Proposed Sale
4,500$220.00$990.0K

View →

Dec 17, 2025Dec 17 4:44 PMSheena Jonathan
Proposed Sale
9,210$228.00$2.1M

View →

Dec 12, 2025Dec 12 10:17 PMSOLOMON MOSHKEVICH
Proposed Sale
4,692$230.76$1.1M

View →

Dec 12, 2025Dec 12 3:07 PMHerm Rosenman Trust
Proposed Sale
48,419$233.13$11.3M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,3860(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,5220(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
1910(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
8560(D)

View →